Showing 21-30 of 45 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Sparing ER stressed human beta cells with novel kinase inhibitors of the unfolded protein response (UPR) | The Regents of the University of California, San Francisco | Feroz Papa | Cures | 01-August-2023 to 31-July-2026 | $960,000.00 |
| Reducing Diabetes Distress in Adults with Type 1 Diabetes: A pragmatic trial in routine diabetes care. | The Regents of the University of California, San Francisco | Danielle Hessler | Improving Lives | 01-August-2023 to 31-July-2026 | $1,743,010.00 |
| Local delivery of immunomodulators to enable systemic immunosuppression-free efficient islet transplantation | The Regents of the University of California, San Francisco | Bhushan Kharbikar | Cures | 01-March-2024 to 28-February-2027 | $285,000.00 |
| Network-based Systems Biology for T1D Drug Repositioning | The Regents of the University of California, Los Angeles | Xia Yang | Improving Lives | 01-May-2021 to 30-November-2025 | $780,961.09 |
| Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts | The Regents of the University of California, Los Angeles | Oluwatayo Ikotun | Cures | 01-February-2024 to 31-January-2027 | $749,996.25 |
| Antigen-specific immunotherapies based on ignored ß-cell antigen determinants. | The Regents of the University of California, Los Angeles | Daniel Kaufman | Cures | 01-October-2024 to 30-September-2026 | $573,101.00 |
| Novel insulin formulations for pumps | Stanford University | Yanxian Zhang | Improving Lives | 01-March-2023 to 28-February-2026 | $243,986.00 |
| Single-arm intervention trial of TWIIST™ AID DEKA Loop insulin pump in pregnant women with pre-existing type 1 diabetes | Stanford University | Tugce Akcan | Improving Lives | 01-March-2025 to 28-February-2027 | $180,600.00 |
| Endothelial cells for islet replacement in diabetes | Stanford University | Martin Neukam | Cures | 01-April-2024 to 31-March-2027 | $251,600.00 |
| Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants | Stanford University | Eric Appel | Cures | 01-January-2025 to 31-December-2026 | $600,000.00 |